
$7.10K
1
1

1 market tracked

No data available
| Market | Platform | Price |
|---|---|---|
![]() | Poly | 5% |
Trader mode: Actionable analysis for identifying opportunities and edge
This market will resolve to "Yes" if the World Health Organization (WHO) declares a new COVID pandemic other than COVID-19 (SARS-CoV-2) between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source will be official announcements from the World Health Organization.
Prediction markets currently give about a 5% chance that the World Health Organization will declare a new coronavirus pandemic before the end of 2026. In simple terms, traders see this as a very unlikely event, estimating roughly a 1 in 20 probability. This shows a high level of collective confidence that a major new pandemic from a novel coronavirus will not be officially declared in the next two years.
Two main factors explain the low probability. First, the scientific understanding of coronaviruses suggests that while new variants emerge frequently, a completely novel virus with high transmissibility and severity jumping to humans is a rare event. The original SARS-CoV-1 outbreak in 2003 and SARS-CoV-2 (COVID-19) in 2019 were separated by 16 years. The market reflects the view that another event of that scale so soon is statistically uncommon.
Second, the current global situation does not show an obvious precursor. While coronavirus surveillance has improved since 2020, no new virus with clear pandemic potential is currently being tracked by major health agencies. The market is essentially pricing in the absence of an immediate threat, though it does acknowledge a small, persistent risk inherent in viral evolution and human-animal interactions.
There are no specific scheduled dates for a pandemic. Instead, the signal to watch is official reporting from health bodies. Key updates would come from the WHO's regular disease outbreak news or emergency committee declarations. A significant shift in market odds would likely follow a WHO statement identifying a novel coronavirus as a "Variant of Concern" or a "Public Health Emergency of International Concern." Monitoring major outbreaks of respiratory illness reported by countries like China or in regions with known coronavirus reservoirs could also provide early clues.
Prediction markets have a mixed record on rare, high-impact events like pandemics. They are generally good at aggregating known information about current risks, which is why the probability is low. However, they can be poor at predicting true "black swan" events that emerge unexpectedly from complex systems. The 5% chance is not a scientific probability but a snapshot of current trader sentiment based on visible evidence. It could change rapidly with a single alarming WHO report, which is a key limitation for forecasting low-probability, high-consequence scenarios.
The market currently prices a 5% probability of the WHO declaring a new coronavirus pandemic before the end of 2026. This is a very low chance, indicating traders see such an event as unlikely within this timeframe. With only $7,000 in total volume, liquidity is thin. This means the current price is more sensitive to individual trades and may not reflect a deep consensus.
Two primary factors suppress the probability. First, the historical precedent for novel coronavirus pandemics is low. Before SARS-CoV-2, the last coronavirus to cause a major global outbreak was SARS in 2002-2004, which was contained. The market appears to price these as rare, decades-apart events. Second, global surveillance and vaccine platform technologies have improved since 2020. While not perfect, these systems could enable faster containment of a novel coronavirus, potentially preventing it from reaching the WHO's pandemic declaration threshold. The 5% price essentially assigns a small but non-zero risk to a surveillance failure or an exceptionally transmissible variant.
The odds would increase sharply with credible reports of a novel coronavirus with high transmissibility causing severe outbreaks outside a localized region. Monitoring for such signals will be critical. Key dates to watch are WHO Global Influenza Programme reports and any emergency committee meetings. Conversely, the "No" position could strengthen if 2025 passes without a major coronavirus outbreak, reinforcing the market's view of a low base rate. The thin liquidity means a single major news event could cause significant price volatility.
AI-generated analysis based on market data. Not financial advice.
$7.10K
1
1
This prediction market asks whether the World Health Organization will declare a new coronavirus pandemic, distinct from COVID-19, by the end of 2026. The resolution depends entirely on an official WHO declaration, making the organization's monitoring and classification systems central to the outcome. The question reflects ongoing scientific concern about the potential for another coronavirus to jump from animals to humans and cause widespread disease, a phenomenon known as zoonotic spillover. Coronaviruses are a large family of viruses, several of which have caused significant human outbreaks in the 21st century, including SARS in 2002-2003, MERS in 2012, and SARS-CoV-2 in 2019. Interest in this market stems from the profound global impact of the COVID-19 pandemic, which has heightened public and institutional awareness of pandemic risks. Governments, public health agencies, and research institutions are now more actively surveilling novel pathogens and assessing pandemic preparedness. The market essentially functions as a collective assessment of the probability of another major coronavirus emergence within a specific three-year window, based on virological trends, surveillance capabilities, and the known behavior of this virus family.
The 21st century has witnessed three major coronavirus outbreaks prior to COVID-19. The first was Severe Acute Respiratory Syndrome (SARS), caused by SARS-CoV-1. It emerged in Guangdong, China, in November 2002 and was contained by July 2003 after spreading to 29 countries, causing over 8,000 cases and 774 deaths. The outbreak led to major revisions in global health security, resulting in the updated International Health Regulations (2005). Nearly a decade later, Middle East Respiratory Syndrome (MERS), caused by MERS-CoV, was first identified in Saudi Arabia in 2012. Unlike SARS, MERS established a persistent zoonotic reservoir in dromedary camels, leading to recurring outbreaks, primarily in the Arabian Peninsula, with a case fatality rate of approximately 35%. These events demonstrated the pandemic potential of coronaviruses. The COVID-19 pandemic, caused by SARS-CoV-2, began in late 2019 and was declared a PHEIC on January 30, 2020, and a pandemic on March 11, 2020. It resulted in an estimated 7 million reported deaths globally as of 2024 and triggered the most significant societal and economic disruption since World War II. This history establishes a clear pattern of novel coronavirus emergence every 8-10 years, informing the rationale for a prediction market focused on the 2024-2026 period.
The declaration of a new coronavirus pandemic would trigger immediate and severe global consequences. Economically, it could disrupt supply chains, shut down international travel, and force widespread business closures, potentially causing a recession worse than that seen in 2020. Stock markets would likely crash, and government debt would soar due to emergency stimulus spending. Politically, it would test international cooperation, potentially leading to border closures, trade restrictions, and blame-shifting between nations. Public trust in health authorities, already strained in many countries, could erode further depending on the response. Socially, a new pandemic would likely reintroduce public health measures like masking, distancing, and quarantine, profoundly affecting education, mental health, and social cohesion. Healthcare systems, many still recovering from COVID-19, would face the risk of collapse under a new surge of patients. The outcome of this prediction market matters to investors, policymakers, public health planners, and businesses that must assess and hedge against catastrophic risk. A 'Yes' resolution would validate concerns about insufficient global preparedness, while a 'No' resolution by 2027 might suggest improved surveillance and containment have broken the historical cycle of coronavirus emergence.
As of late 2024, the WHO continues to monitor several known coronaviruses, including MERS-CoV, which causes sporadic outbreaks. No novel coronavirus causing sustained human-to-human transmission has been identified since SARS-CoV-2. However, surveillance has intensified. In July 2024, the WHO updated its guidance on tracking animal viruses with pandemic potential, listing several coronavirus species alongside influenza and other pathogens. Research published in 2023 and 2024 continues to identify numerous SARS-like coronaviruses in bat populations in Southeast Asia, demonstrating a large natural reservoir. The WHO's technical advisory group met in May 2024 to discuss updating the global genomic surveillance strategy for respiratory pathogens, partly in response to lessons from COVID-19.
An epidemic is a sudden increase in cases of a disease above what is normally expected in a specific geographic area or population. A pandemic is an epidemic that has spread over multiple countries or continents, usually affecting a large number of people. The WHO declares a pandemic based on the worldwide spread of a new disease.
Bats are considered the primary natural reservoir for coronaviruses with pandemic potential, including the progenitors of SARS-CoV-1, MERS-CoV, and SARS-CoV-2. Intermediate hosts like civets (for SARS) and camels (for MERS) have played roles in transmission to humans. Surveillance focuses on wildlife markets and interfaces where humans and these animals interact.
Yes. The WHO declared the H1N1 influenza outbreak a pandemic in June 2009. Prior to that, the term was used descriptively but not as an official declaration under the International Health Regulations. The 2009 H1N1 pandemic was the first declared under the IHR (2005) framework.
A PHEIC is the WHO's highest level of alarm, defined as an extraordinary event that constitutes a public health risk to other countries through international spread and that may require a coordinated international response. It is a formal declaration that triggers specific recommendations for member states. A pandemic is typically declared following or alongside a PHEIC.
Organizations like CEPI aim to develop a safe and effective vaccine within 100 days of identifying a pandemic pathogen. This timeline relies on platform technologies like mRNA, which were proven for COVID-19. However, manufacturing, regulatory approval, and global distribution would add several more months before widespread immunization is achieved.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

No related news found
Add this market to your website
<iframe src="https://predictpedia.com/embed/pKpbrh" width="400" height="160" frameborder="0" style="border-radius: 8px; max-width: 100%;" title="New Coronavirus Pandemic in 2026?"></iframe>